Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Upgrades ResMed to Buy

Citigroup Upgrades ResMed to Buy

Citigroup analyst John Deakin-Bell upgrades ResMed (NYSE:RMD) from Neutral to Buy.

byBenzinga Newsdesk

September 8, 2022

1 minute read

Citigroup analyst John Deakin-Bell upgrades ResMed (NYSE:RMD) from Neutral to Buy.

Movers
News

Why NextEra Energy Stock Is Down

By Erica Kollmann

June 11, 3:32 PM

NextEra Energy shares are trading lower Tuesday. The company reaffirmed its 2024-2026 EPS guidance and issued 2027 targets ahead of its Investor Day event. Here's a look at the details:

NEE

Middlesex Water Company Increases Quarterly Dividend From $0.3125 To $0.325 Per Share

By Benzinga Newsdesk

October 20, 4:20 PM

Middlesex Water Company (NASDAQ:MSEX) announced today that its Board of Directors has declared a cash dividend of $0.325 per share on its common stock, an increase of 4.0% from the $0.3125 per share dividend last

MSEX